For experiments, cells were seeded in 24-well plates at a density of 1 × 105 cells/cm2 in a final volume of 1 mL. To differentiate monocytes toward macrophage phenotype, cells were cultivated for 3 days in complete media supplemented with 100 nM phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich, St. Louis, MO, USA), followed by 24 h cultivation under PMA-free conditions. For the cell viability, THP-1 cells were treated with particle number concentrations of 1 × 107, 1 × 108 and 1 × 109, representing mass concentrations of 0.876, 8.58 and 89.9 μg/mL for TiO2 and 0.912, 9.11 and 92.6 μg/mL for ZrO2 particles in complete culture medium for 12, 24 and 48 h. Therefore, for the cell viability, the particles were analyzed at concentrations between 0 and 100 μg/mL according to the corresponding particle mass concentration applied during experimentation. Concentration-dependent analysis revealed that 1 × 108 and 1 × 109 particles/mL confirmed adverse toxicity effects on macrophages’ viability. Consequently, the particle number concentration of 1 × 107 particles/mL was finally sublethal, and for this reason, was selected for the gene expression assays. In order to assess particle-induced pro-inflammatory gene expression in THP-1 after 12, 24 and 48 h of stimulation by the different particles TiO2, ZrO2 and glass (at particle number concentration of 107 particles/mL), cell culture lysates were collected, immediately centrifuged, transferred to a fresh tube and stored at −80 °C until used for RT-PCR assays. Lipopolysaccharides from Porphyromonas gingivalis (P. gingivalis LPS) were purchased from Sigma-Aldrich. Cells were cultured at 37 °C under 5% CO2 with 1 μg/mL of P. gingivalis LPS for 24 h. The growth medium was then replaced with 100 μL of RPMI 1640 medium containing the TiO2, ZrO2 and glass particles at the 107 particles/mL concentrations. Cells were exposed to these agents for a further 48 h to finalize the experiment. Macrophages cultured under particle-free/LPS conditions were used as negative controls.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.